Related Experiment Video
Updated: Mar 18, 2026
How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
Published on: August 19, 2020
Hyperbilirubinemia in Neonates: Types, Causes, Clinical Examinations, Preventive Measures and Treatments: A Narrative
Sana Ullah1, Khaista Rahman2, Mehdi Hedayati3
1Dept. of Animal Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
Insights
Newborn jaundice (hyperbilirubinemia) is a serious condition requiring prompt treatment. Early diagnosis and therapeutic interventions like phototherapy are crucial to prevent severe complications in infants.
Area of Science:
- Neonatal Medicine
- Pediatrics
- Clinical Biochemistry
Background:
- Neonatal hyperbilirubinemia, commonly known as jaundice, is a prevalent and potentially life-threatening condition in newborns.
- It encompasses both physiological and pathological forms, with varying prevalence across different regions.
- Understanding its multifactorial nature and clinical manifestations is critical for timely intervention.
Purpose of the Study:
- To provide a comprehensive overview of neonatal jaundice.
- To discuss the types, causes, and diagnostic methods for hyperbilirubinemia.
- To outline clinical management strategies, parental guidance, and therapeutic options.
Main Methods:
- A systematic literature search was conducted across major scientific databases (Scopus, PubMed, MEDLINE, Google Scholar, ScienceDirect).
- Keywords included "newborns' hyperbilirubinemia," "newborns' jaundice," "Physiological Jaundice," and "Pathological Jaundice."
- Articles published between 1952 and 2015 were reviewed.
Main Results:
- Jaundice can be associated with breastfeeding and hemolytic causes due to ABO and Rh blood group incompatibilities.
- Maternal-fetal blood group incompatibility can lead to fetal blood hemolysis and severe immune responses.
- Various factors contribute to the development of neonatal jaundice.
Conclusions:
- Neonatal jaundice is readily diagnosable but necessitates immediate treatment to avert serious complications.
- Effective treatment modalities include phototherapy, chemotherapy, and vaccinations.
- Prompt management is essential for favorable infant outcomes.
Background:
Hyperbilirubinemia, or jaundice, is a life threatening disorder in newborns. It is a multifactorial disorder with many symptoms. Generally, the physiological jaundice is the most prevalent type however in some regions pathological jaundice is also common. This review article focuses on a brief introduction to jaundice, its types and causes, measuring the bilirubin level, clinical approaches towards hyperbilirubinemia, different precautionary measures for the parents of babies suffering from hyperbilirubinemia and different remedial therapeutic measures for its treatment.
Methods:
The main databases including Scopus, Pubmed, MEDLINE, Google scholar and Science Direct were researched to obtain the original papers related to the newborns' hyperbilirubinemia. The main terms used to literature search were "newborns' hyperbilirubinemia", "newborns' jaundice", "Physiological Jaundice" and "Patholigical Jaundice". The timeframe included the obtained articles was from 1952 to 2015.
Results:
Neonatal jaundice due to breast milk feeding is also sometimes observed. Hemolytic jaundice occurs because of the incompatibility of blood groups with ABO and Rh factors, when the fetus and mother blood groups are not compatible and the fetus blood crosses the barrier of the umbilical cord before birth causing fetus blood hemolysis owing to severe immune response.
Conclusion:
Jaundice is easily diagnosable however require quick and on the spot treatment. If not treated properly, it leads to many complications. Currently the treatment options for jaundice include photo therapy, chemotherapy, and vaccinations.
